• About Us
    • Fact Checking Policy
    • Ownership & funding information
    • Volunteer
  • Subscribe
  • Letter submission
    • Submissions Policy
  • Contact Us
The Online Citizen Asia
  • Opinion
    • Editorial
    • Commentaries
    • Letters
    • Comments
  • Current Affairs
    • Singapore
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Arts & Culture
    • Consumer Watch
    • NGO
    • Lifestyle
    • Travel
  • Politics
    • Civil Society
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Letters
    • Comments
  • Current Affairs
    • Singapore
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Arts & Culture
    • Consumer Watch
    • NGO
    • Lifestyle
    • Travel
  • Politics
    • Civil Society
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
No Result
View All Result
The Online Citizen Asia
No Result
View All Result

AstraZeneca’s Pascal Soriot: the man behind the vaccine

by The Online Citizen
18/03/2021
in Health
Reading Time: 3 mins read
0
AstraZeneca’s Pascal Soriot: the man behind the vaccine

CEO AstraZeneca Pascal Soriot (Source: AstraZeneca).

by Véronique Dupont

Pascal Soriot has led the charge to make AstraZeneca one of the first pharmaceutical companies in the world to produce a vaccine against COVID-19.

The development of the vaccine with scientists at Oxford University — and their decision to make it available at cost — has made the Anglo-Swedish firm a household name.

Since announcing successful clinical trials and having the vaccine passed by regulators, the company has faced a spate of challenges.

Production and delivery delays of the vaccines in Europe have caused turmoil, while queries over clinical trial data have prompted questions about its effectiveness among the over-65s.

Now, several countries, including France and Germany, have suspended the jab pending an investigation into whether it caused blood clots.

The World Health Organization and the European Medicines Agency have both said the benefits of the vaccine outweigh any risk.

But the attacks have left Soriot, a 61-year-old Frenchman, defending the company on multiple fronts, even as he leads the takeover of US biotech firm Alexion for $39 billion.

With each question or suspension of the jab, AstraZeneca has kept a consistent line: the vaccine is safe and it is cooperating with governments and regulators.

Soriot voiced annoyance with armchair critics in an interview with The Times in December. “I’m a player, I’m not a watcher or a commentator,” he said.

He began his career in Australia, took Australian citizenship and still has a home in Sydney with his family.

He revealed he made final preparations for the merger announcement with Alexion from a quarantine hotel.

On a conference call in February at the time of the company’s annual results, he vigorously defended the company’s work on the life-saving vaccine.

“Has everything been perfect? No,” he said, but stressed the vaccine provided 100 percent protection against the most serious cases of COVID-19.

The last 12 months have been his hardest ever, he admitted to The Times, as he shuttled between the United States, Europe and Australia.

His only company often was his cat, Daisy, he added.

Pharma veteran

Soriot took over as chief executive of AstraZeneca in 2012 and has been no stranger to battles.

He had locked horns with Pfizer even before the US firm tied up with Germany’s BioNTech in the race to develop the first COVID vaccine.

In 2014, Pfizer had tried to takeover AstraZeneca for £69 billion but failed.

Soriot argued that the development of new cancer treatments would suffer — and lives were at stake — if the US firm was allowed to do so.

A graduate of the Maison Alfort veterinary school, southeast of Paris, who holds an MBA from the HEC Paris business school, Soriot entered the pharma industry in the 1980s.

In Australia, he spent years in sales for the French laboratory Roussel Uclaf, which was absorbed by the German pharmaceutical group Hoechst to become Hoechst Marion Roussel in 1995.

He became managing director the following year, then moved to Japan in 1997.

Through a series of mergers, the group became part of the giant Sanofi group.

Soriot then joined the Swiss pharmaceutical company Roche in 2006.

Then, from 2009 to 2010, he headed Genentech, a Roche subsidiary since 1990 which was then bought out in full in 2009 after a hostile takeover bid.

He was poached to lead AstraZeneca in 2012.

The markets remain generally confident in the company thanks to promising drugs in development.

The company’s stock price has almost doubled in five years.

But it is down 2 percent this year, while the FTSE-100 index, of which AstraZeneca is a member, has risen 5 percent since 1 January.

According to analysts, the stock has suffered in recent months from a proposed price for the purchase of Alexion that many consider too high.

– AFP

For just US$7.50 a month, sign up as a subscriber on The Online Citizen Asia (and enjoy ads-free experience on our site) to support our mission to transform TOC into an alternative mainstream press.
Source: AFP
Tags: AFPAstraZenecaCOVID-19

Related Posts

US businesses ‘fear internet curbs in Hong Kong’
AFP

Hong Kong offers free flights after COVID isolation

02/02/2023
US tells vaccinated people in high COVID risk areas to mask again
AFP

White House says US COVID emergency status to end 11 May

31/01/2023
WHO panel in talks on COVID emergency status
AFP

WHO panel in talks on COVID emergency status

27/01/2023
Zero-COVID left in dust as Chinese revellers fuel travel boom
AFP

Zero-COVID left in dust as Chinese revellers fuel travel boom

19/01/2023
China ends quarantine for overseas travellers after years of self-imposed isolation
AFP

China back to ‘normal’ after end of COVID curbs: official

17/01/2023
UK health firm estimates 9,000 COVID deaths in China per day but Chinese govt says only 10 since 7 Dec
AFP

‘Not necessary’ to dwell on COVID death tally, Chinese experts say

11/01/2023
Subscribe
Connect withD
Login
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
Notify of
Connect withD
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
0 Comments
Inline Feedbacks
View all comments

Latest posts

LTA revises ERP rates up after latest review; Gantries reach as high as S$5 for 8:30am – 9:00am

LTA revises ERP rates up after latest review; Gantries reach as high as S$5 for 8:30am – 9:00am

07/02/2023
Stern warnings was an “in-between” solution as CPIB lacks sufficient evidence to prosecute six former KOM executives for bribery, said Indranee Rajah

Stern warnings was an “in-between” solution as CPIB lacks sufficient evidence to prosecute six former KOM executives for bribery, said Indranee Rajah

06/02/2023
19-year-old delivery rider in China covers 5km in 22 minutes to deliver antivenom to woman who had bitten by snake

19-year-old delivery rider in China covers 5km in 22 minutes to deliver antivenom to woman who had bitten by snake

06/02/2023
Why is Gautam Adani’s Indian empire in turmoil?

Adani shares dive again as Indian opposition stages demos

06/02/2023
Josephine Teo defends SPH Media Trust in Parliament on its circulation scandal; Commitment of S$900 million funding will still be made available

Josephine Teo defends SPH Media Trust in Parliament on its circulation scandal; Commitment of S$900 million funding will still be made available

06/02/2023
Japanese-Canadian junior high school girl breaks national record with 3km in 9:02 mins

“I want my normal life back,” Sherry Drury withdraws from National Junior High School Tournament due to overheated public attention

06/02/2023
FY2023 Budget Statement to be delivered by Lawrence Wong on 14 Feb, 3.30pm

FY2023 Budget Statement to be delivered by Lawrence Wong on 14 Feb, 3.30pm

06/02/2023

Scholar, lawmakers and journalist among Hong Kongers on trial

06/02/2023

Trending posts

Former Singaporean shares change of life in Australia with annual pay of S$80,000 as a plumber

Former Singaporean shares change of life in Australia with annual pay of S$80,000 as a plumber

by Yee Loon
30/01/2023
25

...

Cognizant India transfers staff to work in Singapore as recently as this year

Local IT grads can’t find jobs while engineers constantly transferred from India to work in SG under CECA

by Correspondent
05/02/2023
93

...

They have done a fine job of confusing us about the jobs situation

They have done a fine job of confusing us about the jobs situation

by Augustine Low
01/02/2023
47

...

Adani’s brother runs SG company and registers as director with local ID

Adani’s brother runs SG company and registers as director with local ID

by Correspondent
03/02/2023
26

...

No response from Josephine Teo on whether Mediacorp has been instructed to stop coverage of SMT circulation scandal

No response from Josephine Teo over alleged blackout of coverage by Mediacorp over SMT circulation scandal

by Terry Xu
06/02/2023
11

...

Excessively charging for an essential need, and calling it affordable because people still can pay for it?

by Terry Xu
31/01/2023
40

...

March 2021
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
« Feb   Apr »

The Online Citizen is a regional online publication based in Taiwan and formerly Singapore’s longest-running independent online media platform.

Navigation

  • Editorial
  • Commentaries
  • Opinion
  • Politics
  • Community

Support

  • Contact Us
  • Letter submission
  • Membership subscription

Follow Us

  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Fact Checking Policy
  • Privacy Policy

© 2022 - 2023 The Online Citizen Asia

No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Comments
  • Current Affairs
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Civil Society
    • Arts & Culture
    • Consumer Watch
    • NGO
  • Politics
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
  • Lifestyle
    • Travel
  • Subscribers login

© 2022 - 2023 The Online Citizen Asia

wpDiscuz